Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Haber

Showing results (121-130 of 186) with videos related to

Pageof 19
Sort By:
International Journal of Cancer|February 22, 2025
Polyamine depletion limits progression of acute leukaemiaWeiman Gao, Mawar Karsa, Lin Xiao, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemiaMichael J Brisco, Sue Latham, Rosemary Sutton, et al.
Molecular Oncology|February 21, 2025
The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastomaMujahid Azfar, Weiman Gao, Chris Van den Haute, et al.
The Journal of Pathology|October 20, 2011
The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitroBelamy B Cheung, Jessica Koach, Owen Tan, et al.
NPJ Genomic Medicine|July 3, 2026
Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancerKate Hetherington, Jacqueline D Hunter, Mark W Donoghoe, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 14, 2025
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastomaKimberley M Hanssen, Jayne Murray, Ruby Pandher, et al.
British Journal of Haematology|December 2, 2017
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in childrenRosemary Sutton, Nicola C Venn, Tamara Law, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 13, 2024
FDA-approved disulfiram as a novel treatment for aggressive leukemiaMawar Karsa, Lin Xiao, Emma Ronca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2016
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and ProgressionNicholas F Evageliou, Michelle Haber, Annette Vu, et al.
Biochemical Pharmacology|June 29, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.
Pageof 19

Showing results (121-130 of 186) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|February 22, 2025
Polyamine depletion limits progression of acute leukaemiaWeiman Gao, Mawar Karsa, Lin Xiao, et al.
The Journal of Molecular Diagnostics : JMD|March 28, 2009
Determining the repertoire of IGH gene rearrangements to develop molecular markers for minimal residual disease in B-lineage acute lymphoblastic leukemiaMichael J Brisco, Sue Latham, Rosemary Sutton, et al.
Molecular Oncology|February 21, 2025
The polyamine transporter ATP13A3 mediates difluoromethylornithine-induced polyamine uptake in neuroblastomaMujahid Azfar, Weiman Gao, Chris Van den Haute, et al.
The Journal of Pathology|October 20, 2011
The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitroBelamy B Cheung, Jessica Koach, Owen Tan, et al.
NPJ Genomic Medicine|July 3, 2026
Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancerKate Hetherington, Jacqueline D Hunter, Mark W Donoghoe, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 14, 2025
Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastomaKimberley M Hanssen, Jayne Murray, Ruby Pandher, et al.
British Journal of Haematology|December 2, 2017
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in childrenRosemary Sutton, Nicola C Venn, Tamara Law, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 13, 2024
FDA-approved disulfiram as a novel treatment for aggressive leukemiaMawar Karsa, Lin Xiao, Emma Ronca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2016
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and ProgressionNicholas F Evageliou, Michelle Haber, Annette Vu, et al.
Biochemical Pharmacology|June 29, 2014
High-throughput screening identifies Ceefourin 1 and Ceefourin 2 as highly selective inhibitors of multidrug resistance protein 4 (MRP4)Leanna Cheung, Claudia L Flemming, Fujiko Watt, et al.
Pageof 19